In vivo multi-tissue corticosteroid microarray time series available online at Public Expression Profile Resource (PEPR).

Gene microarrays are becoming a key tool for the analysis of changes in gene expression in a variety of conditions. Use of microarrays to analyze drug responses has mainly been restricted to comparing treated versus untreated samples at a few time points. Such data do not permit the use of another important tool, pharmacokinetic/pharmacodynamic (PK/PD) modeling. Such modeling requires the simultaneous analysis of pharmacokinetic data along with time series data on dynamic responses. This report describes data obtained from two extended microarray time series (rat liver and skeletal muscle) for the in vivo responses to a single bolus dose of methylprednisolone that are uniquely available online in a single gene query format. Use of these data does not require any a priori knowledge or software normally necessary for the analysis of microarray data. Since the pharmacokinetic data and receptor model have been published, the results are amenable to PK/PD and pharmacogenomic evaluation.

[1]  Eric P. Hoffman,et al.  The PEPR GeneChip data warehouse, and implementation of a dynamic time series query tool (SGQT) with graphical interface , 2004, Nucleic Acids Res..

[2]  M. Takiguchi,et al.  The Glucocorticoid-responsive Gene Cascade , 1997, The Journal of Biological Chemistry.

[3]  William J Jusko,et al.  Diversity of mechanism-based pharmacodynamic models. , 2003, Drug metabolism and disposition: the biological fate of chemicals.

[4]  R. Ramakrishnan,et al.  Fifth-Generation Model for Corticosteroid Pharmacodynamics: Application to Steady-State Receptor Down-Regulation and Enzyme Induction Patterns During Seven-Day Continuous Infusion of Methylprednisolone in Rats , 2002, Journal of Pharmacokinetics and Pharmacodynamics.

[5]  Jin Y. Jin,et al.  Modeling of Corticosteroid Pharmacogenomics in Rat Liver Using Gene Microarrays , 2003, Journal of Pharmacology and Experimental Therapeutics.

[6]  M. Matsuda,et al.  Activation of R-Ras by Ras-Guanine Nucleotide-releasing Factor* , 1997, The Journal of Biological Chemistry.

[7]  L. Panlilio,et al.  The Cannabinoid CB1 Antagonist N-Piperidinyl-5-(4-chlorophenyl)-1-(2,4-dichlorophenyl) -4-methylpyrazole-3-carboxamide (SR-141716A) Differentially Alters the Reinforcing Effects of Heroin under Continuous Reinforcement, Fixed Ratio, and Progressive Ratio Schedules of Drug Self-Administration in Rats , 2003, Journal of Pharmacology and Experimental Therapeutics.

[8]  Matthias Görlach,et al.  DNA-dependent protein kinase (DNA-PK) phosphorylates nuclear DNA helicase II/RNA helicase A and hnRNP proteins in an RNA-dependent manner. , 2004, Nucleic acids research.

[9]  Richard R. Almon,et al.  Fourth-Generation Model for Corticosteroid Pharmacodynamics: A Model for Methylprednisolone Effects on Receptor/Gene-Mediated Glucocorticoid Receptor Down-Regulation and Tyrosine Aminotransferase Induction in Rat Liver , 1998, Journal of Pharmacokinetics and Biopharmaceutics.

[10]  Richard R. Almon,et al.  Dose-Dependence and Repeated-Dose Studies for Receptor/Gene-Mediated Pharmacodynamics of Methylprednisolone on Glucocorticoid Receptor Down-Regulation and Tyrosine Aminotransferase Induction in Rat Liver , 1998, Journal of Pharmacokinetics and Biopharmaceutics.

[11]  S. Akira,et al.  CCAAT/enhancer‐binding protein β is required for activation of genes for ornithine cycle enzymes by glucocorticoids and glucagon in primary‐cultured hepatocytes , 2001 .

[12]  R R Almon,et al.  Molar quantification of specific messenger ribonucleic acid expression in northern hybridization using cRNA standards. , 1993, Analytical biochemistry.

[13]  D. DuBois,et al.  Pharmacokinetic/Pharmacodynamic models for corticosteroid receptor down-regulation and glutamine synthetase induction in rat skeletal muscle by a Receptor/Gene-mediated mechanism. , 1999, The Journal of pharmacology and experimental therapeutics.